LifeMD(LFMD) - 2025 Q3 - Earnings Call Transcript
LifeMD (NasdaqGM:LFMD) Q3 2025 Earnings Call November 17, 2025 04:30 PM ET Company ParticipantsJustin Schreiber - Chairman and CEOEduardo Martinez-Montes - Biotechnology Equity Research AssociateMarc Benathen - CFOConference Call ParticipantsDavid Larsen - Managing Director and AnalystSteven Valiquette - Managing Director and Healthcare Technology and Distribution AnalystAnderson Schock - MedTech Equity Research AnalystSarah James - Managing Director and Equity Analyst for Healthcare Services and HCITOperat ...